牛叉诊股

[{"date":"2025.11.19","stock":"1.64","trade":"-1.93","ind":"-0.00"},{"date":"2025.11.18","stock":"0.21","trade":"-1.16","ind":"-0.92"},{"date":"2025.11.17","stock":"-0.71","trade":"-1.58","ind":"-0.11"},{"date":"2025.11.14","stock":"-0.98","trade":"0.97","ind":"-1.93"},{"date":"2025.11.13","stock":"1.06","trade":"1.58","ind":"1.78"},{"date":"2025.11.12","stock":"-0.07","trade":"0.46","ind":"-0.36"},{"date":"2025.11.11","stock":"0.43","trade":"0.64","ind":"-1.03"},{"date":"2025.11.10","stock":"1.45","trade":"1.26","ind":"0.18"},{"date":"2025.11.07","stock":"1.69","trade":"-0.31","ind":"-0.36"},{"date":"2025.11.06","stock":"-0.07","trade":"-0.47","ind":"1.73"},{"date":"2025.11.05","stock":"0.00","trade":"0.13","ind":"0.37"},{"date":"2025.11.04","stock":"-1.02","trade":"-1.91","ind":"-1.71"},{"date":"2025.11.03","stock":"-0.22","trade":"0.77","ind":"0.19"},{"date":"2025.10.31","stock":"1.40","trade":"3.64","ind":"-1.14"},{"date":"2025.10.30","stock":"-2.16","trade":"-1.21","ind":"-1.16"},{"date":"2025.10.29","stock":"0.00","trade":"0.27","ind":"1.95"},{"date":"2025.10.28","stock":"1.46","trade":"-0.37","ind":"-0.44"},{"date":"2025.10.27","stock":"0.59","trade":"0.79","ind":"1.51"},{"date":"2025.10.24","stock":"2.33","trade":"-0.38","ind":"2.02"},{"date":"2025.10.23","stock":"-0.97","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"-0.74","trade":"0.67","ind":"-0.62"}]

花园生物,深证成指,化学制药指数

压力支撑

该股压力位为14.13元，支撑位为13.86元。

[{"text":"\u538b\u529b\u4f4d","value":"14.13","date":1763481600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.86","date":1763481600,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.1资金面打败了68%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：11月19日 20:34

机构今日流向(万元)	-2145.75	机构5日流向(万元)	-6670.10
机构10日流向(万元)	-8482.61	机构20日流向(万元)	-17509.56

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加765.77万股，其中基金净减仓6家，主力净增仓52家，请投资者中长期谨慎为宜。

截止2025-06-30，共130家主力机构（基金126家，一般法人4家），持仓量总计17836.89万股，占流通A股33.36%
其中，基金持仓与2024-12-31相比：
增仓：11家，增持 112.94万股
减仓：17家，减持 22.90万股
新出现在主力名单中：96家，持有1833.27万股
从主力名单中消失：44家，原持有924.49万股

消息面诊股

诊断结果：5.5消息面打败了33%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	取消监事会	2025-09-02
一般消息	股东大会	临时股东大会	2025-08-16
一般消息	分红转增	不分配不转增	2025-08-16
一般消息	募资投向		2025-08-16
一般消息	重大事项	关联交易	2025-04-15
利好	分红转增	10派1.14元(含税)	2025-03-25
一般消息	重大事项	关联交易	2025-03-25
重大利好	业绩预告	业绩大幅上升	2025-01-13

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	1条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：3.1行业面打败了42%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2025.11.19","price":"-0.00","value":"-1.93"},{"date":"2025.11.18","price":"-0.92","value":"-1.16"},{"date":"2025.11.17","price":"-0.11","value":"-1.58"},{"date":"2025.11.14","price":"-1.93","value":"0.97"},{"date":"2025.11.13","price":"1.78","value":"1.58"},{"date":"2025.11.12","price":"-0.36","value":"0.46"},{"date":"2025.11.11","price":"-1.03","value":"0.64"},{"date":"2025.11.10","price":"0.18","value":"1.26"},{"date":"2025.11.07","price":"-0.36","value":"-0.31"},{"date":"2025.11.06","price":"1.73","value":"-0.47"},{"date":"2025.11.05","price":"0.37","value":"0.13"},{"date":"2025.11.04","price":"-1.71","value":"-1.91"},{"date":"2025.11.03","price":"0.19","value":"0.77"},{"date":"2025.10.31","price":"-1.14","value":"3.64"},{"date":"2025.10.30","price":"-1.16","value":"-1.21"},{"date":"2025.10.29","price":"1.95","value":"0.27"},{"date":"2025.10.28","price":"-0.44","value":"-0.37"},{"date":"2025.10.27","price":"1.51","value":"0.79"},{"date":"2025.10.24","price":"2.02","value":"-0.38"},{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.62","value":"0.67"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	富祥药业	72.86%	24.49%	5.4分
2	康芝药业	51.91%	27.57%	6.4分
3	*ST景峰	33.98%	9.50%	5.6分
4	民生健康	23.63%	17.27%	6.0分
5	海南海药	22.45%	17.46%	5.8分
6	宏源药业	18.23%	-6.94%	5.4分
7	通化金马	14.41%	1.09%	5.5分
8	赛分科技	13.36%	6.71%	6.3分
9	前沿生物	12.09%	-6.84%	5.8分
10	ST复华	11.40%	3.83%	4.2分
11	海辰药业	10.42%	13.49%	5.1分
12	常山药业	10.28%	11.39%	5.6分
13	莱美药业	10.21%	-0.96%	5.6分
14	信立泰	10.00%	2.25%	7.1分
15	山河药辅	9.12%	7.72%	5.7分
16	海思科	8.56%	3.96%	7.3分
17	南新制药	8.39%	-5.20%	5.4分
18	新和成	8.21%	-1.74%	6.5分
19	华特达因	7.20%	-2.76%	5.8分
20	京新药业	7.18%	10.03%	5.9分
21	尔康制药	6.74%	-2.06%	5.7分
22	ST天圣	6.50%	-0.37%	5.3分
23	*ST苏吴	6.25%	4.08%	5.2分
24	纳微科技	6.23%	-2.15%	6.1分
25	花园生物	6.10%	1.21%	6.4分
26	海翔药业	6.02%	-1.44%	4.9分
27	润都股份	5.42%	-0.93%	6.0分
28	威尔药业	5.15%	-2.14%	6.9分
29	溢多利	4.90%	-0.95%	5.1分
30	迪哲医药	4.69%	2.06%	6.0分
31	百利天恒	4.03%	2.34%	6.2分
32	ST诺泰	4.01%	-3.28%	5.8分
33	华东医药	3.98%	-2.90%	6.6分
34	-	3.79%	-0.93%	分
35	赛托生物	3.62%	-0.64%	5.5分
36	天新药业	3.43%	0.50%	5.8分
37	津药药业	3.29%	-0.68%	6.2分
38	奥锐特	3.01%	-3.21%	5.6分
39	国邦医药	2.95%	-2.79%	6.4分
40	东诚药业	2.80%	-6.11%	5.6分
41	汉商集团	2.53%	-1.27%	6.7分
42	联环药业	2.41%	-10.32%	4.8分
43	河化股份	1.97%	2.92%	7.1分
44	西点药业	1.75%	0.63%	6.1分
45	金石亚药	1.72%	-0.17%	6.1分
46	首药控股	1.72%	3.62%	6.1分
47	海正药业	1.42%	-5.81%	5.2分
48	海欣股份	1.33%	-1.29%	5.7分
49	北大医药	1.26%	-4.04%	6.0分
50	亚太药业	1.17%	-13.25%	4.9分
51	华仁药业	1.17%	-3.36%	5.7分
52	福安药业	1.12%	-3.85%	4.8分
53	拓新药业	0.73%	-1.67%	5.3分
54	百济神州	0.73%	-3.27%	5.9分
55	天宇股份	0.68%	-0.83%	5.6分
56	普洛药业	0.59%	-1.10%	6.5分
57	海普瑞	0.42%	-2.91%	6.1分
58	苑东生物	0.34%	-5.35%	5.5分
59	丰原药业	0.29%	-1.87%	5.9分
60	易明医药	0.10%	-4.96%	4.7分
61	亚虹医药	0.10%	1.22%	5.6分
62	兴齐眼药	0.01%	-3.07%	5.0分
63	金陵药业	0.00%	-3.62%	5.8分
64	健友股份	0.00%	-2.82%	5.6分
65	川宁生物	-0.18%	-4.21%	4.6分
66	福元医药	-0.30%	3.00%	6.9分
67	华润双鹤	-0.32%	-3.57%	5.2分
68	莎普爱思	-0.49%	-1.45%	6.1分
69	浙江医药	-0.56%	-4.94%	5.0分
70	华邦健康	-0.59%	-1.56%	6.5分
71	金城医药	-0.59%	-4.03%	4.7分
72	奥翔药业	-0.59%	-2.70%	6.2分
73	新华制药	-0.78%	-2.94%	6.1分
74	仟源医药	-0.82%	-1.62%	6.0分
75	仙琚制药	-0.83%	-2.83%	5.9分
76	健康元	-1.06%	-3.51%	5.7分
77	德展健康	-1.15%	-2.93%	4.5分
78	共同药业	-1.24%	-3.72%	5.3分
79	本立科技	-1.32%	-2.44%	5.9分
80	立方制药	-1.39%	-7.33%	5.7分
81	双鹭药业	-1.41%	-2.29%	5.9分
82	*ST三圣	-1.41%	-5.39%	4.6分
83	誉衡药业	-1.83%	-6.14%	5.1分
84	富士莱	-1.93%	-1.42%	5.1分
85	中关村	-2.03%	-1.85%	6.0分
86	罗欣药业	-2.18%	-2.18%	5.9分
87	司太立	-2.20%	-8.73%	5.8分
88	宣泰医药	-2.21%	-3.10%	5.2分
89	圣诺生物	-2.22%	-1.19%	5.8分
90	-	-2.26%	-3.96%	分
91	哈药股份	-2.39%	-2.39%	5.7分
92	东北制药	-2.43%	-2.26%	6.2分
93	*ST赛隆	-2.73%	-2.65%	4.5分
94	键凯科技	-2.78%	-4.58%	5.0分
95	-	-2.88%	-9.25%	分
96	北陆药业	-2.96%	-5.97%	4.9分
97	泽璟制药	-3.01%	-0.29%	5.7分
98	华北制药	-3.09%	-3.72%	4.9分
99	鲁抗医药	-3.34%	-3.98%	5.5分
100	悦康药业	-3.39%	-3.21%	6.2分
101	九典制药	-3.47%	-2.67%	5.1分
102	博瑞医药	-3.50%	-3.61%	5.0分
103	华纳药厂	-3.68%	-2.22%	5.7分
104	同和药业	-3.80%	-1.42%	6.2分
105	复旦张江	-3.85%	-3.64%	5.1分
106	丽珠集团	-3.87%	-4.02%	5.5分
107	国药现代	-3.96%	-2.43%	6.2分
108	海森药业	-4.01%	-1.65%	5.4分
109	-	-4.10%	-8.58%	分
110	复星医药	-4.20%	-2.92%	5.2分
111	昂利康	-4.41%	-7.13%	6.2分
112	亿帆医药	-4.45%	-5.47%	4.9分
113	人福医药	-4.48%	-3.69%	5.3分
114	新天地	-4.50%	-2.41%	5.5分
115	-	-4.58%	-7.39%	分
116	泰恩康	-4.72%	1.68%	4.1分
117	-	-5.14%	-7.08%	分
118	微芯生物	-5.49%	-4.65%	4.8分
119	卫信康	-5.75%	-2.59%	6.5分
120	千红制药	-5.84%	-6.15%	4.9分
121	华海药业	-5.87%	-3.78%	4.9分
122	益方生物	-6.02%	-0.30%	5.4分
123	汇宇制药	-6.06%	-2.14%	5.4分
124	恩华药业	-6.24%	-3.16%	5.7分
125	恒瑞医药	-6.36%	-1.59%	6.3分
126	永安药业	-6.57%	-5.45%	3.7分
127	亨迪药业	-6.67%	-9.74%	4.7分
128	科伦药业	-6.94%	0.81%	5.6分
129	科源制药	-7.01%	-4.60%	4.7分
130	灵康药业	-7.57%	-6.77%	5.1分
131	艾力斯	-8.00%	-4.63%	5.6分
132	吉贝尔	-8.12%	-6.12%	5.4分
133	小方制药	-8.39%	-6.62%	5.0分
134	-	-8.81%	-8.44%	分
135	-	-9.95%	-8.19%	分
136	美诺华	-10.62%	-5.03%	4.5分
137	舒泰神	-10.98%	-8.14%	5.0分
138	-	-11.05%	-9.56%	分
139	奥赛康	-11.37%	-7.75%	5.5分
140	诚意药业	-11.72%	-3.73%	5.1分
141	力生制药	-11.76%	-3.07%	5.5分
142	一品红	-12.01%	2.39%	6.1分
143	上海谊众	-12.11%	-3.31%	5.3分
144	海创药业	-12.16%	-5.74%	5.3分
145	贝达药业	-12.68%	-5.64%	5.4分
146	翰宇药业	-12.99%	-6.23%	5.0分
147	盟科药业	-13.60%	-10.23%	5.0分
148	多瑞医药	-15.51%	-14.29%	4.9分
149	向日葵	-16.08%	-5.26%	4.3分
150	广生堂	-16.18%	-5.70%	4.4分
151	辰欣药业	-18.84%	-7.79%	4.9分
152	新诺威	-21.08%	2.15%	5.9分
153	必贝特	-	-8.60%	3.7分
154	东亚药业	-	-1.19%	5.5分
155	神奇制药	-	2.29%	6.3分
156	哈三联	-	2.72%	5.8分
157	能特科技	-	-6.14%	5.2分
158	广济药业	-	-0.91%	6.1分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.2基本面打败了61%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（65分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 42/219 ， 63/219。

[{"date":"2025-09-30","value":"7.05","vol":"1.46"},{"date":"2025-06-30","value":"4.92","vol":"1.21"},{"date":"2025-03-31","value":"2.94","vol":"-0.17"},{"date":"2024-12-31","value":"10.12","vol":"19.51"},{"date":"2024-09-30","value":"8.00","vol":"4.61"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	7.05	4.92	2.94	10.12	8.00
行业(%)	1.46	1.21	-0.17	19.51	4.61

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"55.25","vol":"49.47"},{"date":"2025-06-30","value":"55.94","vol":"49.43"},{"date":"2025-03-31","value":"56.80","vol":"49.23"},{"date":"2024-12-31","value":"58.44","vol":"50.77"},{"date":"2024-09-30","value":"58.17","vol":"50.51"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	55.25	55.94	56.80	58.44	58.17
行业(%)	49.47	49.43	49.23	50.77	50.51

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 64/219 ， 79/219。

[{"date":"2025-09-30","value":"-0.20","vol":"141.76"},{"date":"2025-06-30","value":"5.86","vol":"78.53"},{"date":"2025-03-31","value":"-1.18","vol":"-0.84"},{"date":"2024-12-31","value":"13.58","vol":"17.76"},{"date":"2024-09-30","value":"4.43","vol":"45.69"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-0.20	5.86	-1.18	13.58	4.43
行业(%)	141.76	78.53	-0.84	17.76	45.69

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-3.07","vol":"-5.21"},{"date":"2025-06-30","value":"13.67","vol":"56.29"},{"date":"2025-03-31","value":"5.50","vol":"-21.21"},{"date":"2024-12-31","value":"60.76","vol":"-20.55"},{"date":"2024-09-30","value":"62.13","vol":"-32.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-3.07	13.67	5.50	60.76	62.13
行业(%)	-5.21	56.29	-21.21	-20.55	-32.33

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 124/219 ， 140/219。

[{"date":"2025-09-30","value":"0.16","vol":"0.31"},{"date":"2025-06-30","value":"0.11","vol":"0.21"},{"date":"2025-03-31","value":"0.06","vol":"0.10"},{"date":"2024-12-31","value":"0.23","vol":"0.43"},{"date":"2024-09-30","value":"0.17","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.16	0.11	0.06	0.23	0.17
行业(次)	0.31	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.53","vol":"1.95"},{"date":"2025-06-30","value":"0.35","vol":"1.31"},{"date":"2025-03-31","value":"0.17","vol":"0.67"},{"date":"2024-12-31","value":"0.64","vol":"3.22"},{"date":"2024-09-30","value":"0.50","vol":"2.18"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.53	0.35	0.17	0.64	0.50
行业(次)	1.95	1.31	0.67	3.22	2.18

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"23.43","vol":"4.36"},{"date":"2025-06-30","value":"42.33","vol":"2.81"},{"date":"2025-03-31","value":"44.14","vol":"-28.76"},{"date":"2024-12-31","value":"63.66","vol":"-371.46"},{"date":"2024-09-30","value":"25.39","vol":"-9.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	23.43	42.33	44.14	63.66	25.39
行业	4.36	2.81	-28.76	-371.46	-9.87

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.56","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.08","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	2.56	-	3.08	-
行业	0.00	1.72	0.00	1.99	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/219 ， 51/219。

[{"date":"2025-09-30","value":"2.06","vol":"3.49"},{"date":"2025-06-30","value":"1.99","vol":"3.67"},{"date":"2025-03-31","value":"2.14","vol":"3.59"},{"date":"2024-12-31","value":"1.94","vol":"3.34"},{"date":"2024-09-30","value":"2.14","vol":"3.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.06	1.99	2.14	1.94	2.14
行业	3.49	3.67	3.59	3.34	3.66

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.43","vol":"2.74"},{"date":"2025-06-30","value":"1.32","vol":"2.89"},{"date":"2025-03-31","value":"1.36","vol":"2.81"},{"date":"2024-12-31","value":"1.24","vol":"2.64"},{"date":"2024-09-30","value":"1.38","vol":"2.92"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.43	1.32	1.36	1.24	1.38
行业	2.74	2.89	2.81	2.64	2.92

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 32/219 ， 49/219。

[{"date":"2025-09-30","value":"42.19","vol":"33.75"},{"date":"2025-06-30","value":"40.98","vol":"33.79"},{"date":"2025-03-31","value":"39.63","vol":"34.04"},{"date":"2024-12-31","value":"42.66","vol":"34.19"},{"date":"2024-09-30","value":"43.20","vol":"33.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	42.19	40.98	39.63	42.66	43.20
行业(%)	33.75	33.79	34.04	34.19	33.02

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.73","vol":"0.94"},{"date":"2025-06-30","value":"0.69","vol":"0.88"},{"date":"2025-03-31","value":"0.66","vol":"1.46"},{"date":"2024-12-31","value":"0.74","vol":"0.84"},{"date":"2024-09-30","value":"0.76","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.73	0.69	0.66	0.74	0.76
行业(%)	0.94	0.88	1.46	0.84	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
东方证券	2025-08-21	增持

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"4.80","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.84","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.92","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.09","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.35","blueLineValue":"0.80","type":"YC"}]

[花园生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]